BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24877132)

  • 1. In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.
    Colciago A; Ruscica M; Mornati O; Piccolella M; Montagnani-Marelli M; Eberini I; Festuccia C; Magni P; Motta M; Negri-Cesi P
    Biomed Res Int; 2014; 2014():801473. PubMed ID: 24877132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.
    Dondi D; Piccolella M; Biserni A; Della Torre S; Ramachandran B; Locatelli A; Rusmini P; Sau D; Caruso D; Maggi A; Ciana P; Poletti A
    Endocr Relat Cancer; 2010 Sep; 17(3):731-42. PubMed ID: 20562232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
    Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
    Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
    Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
    Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.
    Muthusamy S; Andersson S; Kim HJ; Butler R; Waage L; Bergerheim U; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20090-4. PubMed ID: 22114194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.
    Lattrich C; Stegerer A; Häring J; Schüler S; Ortmann O; Treeck O
    Steroids; 2013 Feb; 78(2):195-202. PubMed ID: 23153457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
    Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
    Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
    Dey P; Ström A; Gustafsson JÅ
    Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
    Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
    Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
    Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM
    PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.
    Yun H; Xie J; Olumi AF; Ghosh R; Kumar AP
    Oncotarget; 2015 May; 6(13):11600-13. PubMed ID: 25816367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.
    Re A; Aiello A; Nanni S; Grasselli A; Benvenuti V; Pantisano V; Strigari L; Colussi C; Ciccone S; Mazzetti AP; Pierconti F; Pinto F; Bassi P; Gallucci M; Sentinelli S; Trimarchi F; Bacchetti S; Pontecorvi A; Lo Bello M; Farsetti A
    Mol Endocrinol; 2011 Dec; 25(12):2003-16. PubMed ID: 22052999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
    Miyamoto H; Yeh S; Lardy H; Messing E; Chang C
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
    Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Estrogen Receptor β Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.
    Mizoguchi S; Mori K; Wang Z; Liu T; Funahashi Y; Sato F; DeFranco DB; Yoshimura N; Mimata H
    Prostate; 2017 May; 77(7):803-811. PubMed ID: 28181685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
    Zellweger T; Stürm S; Rey S; Zlobec I; Gsponer JR; Rentsch CA; Terracciano LM; Bachmann A; Bubendorf L; Ruiz C
    Endocr Relat Cancer; 2013 Jun; 20(3):403-13. PubMed ID: 23580588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.
    Weihua Z; Lathe R; Warner M; Gustafsson JA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13589-94. PubMed ID: 12370428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.